|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | LEOPARD-II:A randomized phase II study of radiochemotherapy RCT with 5FU and cisplatin plusminus cetuximab Cet in unresectable locally advanced esophageal cancer LAEC显示文摘 | Rades D Moehler MH Debus J | 2014 | J Clin Oncol2014，，： | 1 |
| 2 | Safety and efficacy of CPT-11/CF/5-Fu(IFL) versus FLF in previously untreaeed advanced or metastatic adoenocarcinoma of the stomach or gastroesophageal junction显示文摘 | Moehler MH Siebler J Hoehler T | 2003 | Proc AmSoc Clin Oncol2003，22，5： | 1 |
| 3 | Safety and efficacy of CPT - 11/CF/5 - FU(IFL) versus FLF in previously unereaeed advanced or metzstatis adoenocarcinoma of the stomach or gastroesophageal junction 显示文摘 | Moehler MH Siebler J Hoehler T | 2003 | Proc Amsoc Clin Ooco12003，22，5： | 1 |
| 4 | Safety and efficacy of CPT-11/CF/5-Fu(IFL) versus FLF inpreviouslyuntreaeedadvanced or metastaticadoenocarcinoma of the stomach orgastroesophageal junction显示文摘 | Moehler MH Siebler J Hoehler T | | PmcAmSocClinOncol0，，： | 1 |
| 5 | Safety and efficacy CPT - 11/cF/5 - Fu (IFL) versus FLF in previously untreated advanced or metastatic adoenocarcmoma of the stomach or gastroesophaged junction 显示文摘 | Moehler MH Siebler J Hoehler T | 2003 | Proc Amsoc Clin Oncol2003，22，： | 1 |
| 6 | Docetaxel, oxaliplatin, andcapecitabine( TEX regimen)for patients with metastatic gastric cancer: Interim results from a phase 1I trial by the German AIO Group 显示文摘 | Moehler MH Thuss-Patience P Arnold D | 2009 | J Clin Oncol( Meeting Abstracts)2009，27，6： | 1 |
| 7 | Docetaxel, ox- aliplatin, and capecitabine (TEX regimen) for patients with meta- static gastric cancer : Interim results from a phase II trial by the Ger- man AIO Group显示文摘 | Moehler MH Thuss - Patience P Arnold D | 2009 | J Clin Oncol2009，27，： | 1 |
| 8 | Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased phagocytosis,maturation,and cross-presentation by dendritic cells显示文摘 | Moehler MH Zeidler M Wilsberg V | 2005 | Hum Gene Ther2005，16，8： | 1 |
| 9 | Safety and efficacy of CPT- 11/CF/5 -Fu (IFL) versus FLF in previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction 显示文摘 | Siebler J Hoehler T | 2003 | Proc Am Soc Clin Oncol2003，22，： | 1 |
| 10 | A randomized, double-blind, muhicenter phase Ⅱ AIO trial with gemcitabine plus sorafenib versus gemcitabine plus placebo in patients with chemotherapy-naive advanced or metastatic biliary tract cancer: First safety and efficacy data 显示文摘 | Moehler MH Schimanski CC Kanzler S | 2011 | J Clin Oncol2011，，： | 1 |
| 11 | An open-label,multicenter phase II trial of sunitinib for patients with chemorefractory metastatic gastric cancer显示文摘 | Moehler MH Hartmann JT Lordick F | 2010 | J Clin Oncol2010，，14： | 1 |
| 12 | Safety and efficacy of CPT-11/cF/5-FU(IFL) versus FLF in previously untreated advanced or metastatic adoenocarcinoma of the stomach or gastroesophageal junction显示文摘 | Moehler MH Siebler J Hoehler T | 2003 | Proc AmSoc Clin Oncol2003，22，： | 1 |
| 13 | Docetaxel,oxaliplatin,and capecitabine (TEX regimen) for patients with metastatic gastric cancer:Interim results from a phase Ⅱ trial by the German AIO Group 显示文摘 | Moehler MH Thuss-Patience P Arnold D | 2009 | J Clin Oncol (Meeting Abstracts)2009，27，： | 1 |
| 14 | Parvovirus H-1-induced tumor cell death enhances human immune response in vitro via increased pbagocytosis,maturation,and cross-presentation by dendritic cells显示文摘 | Moehler MH Zeidler M Wilsberg V | 2005 | Human Gene Ther2005，16，8： | 1 |
| 15 | Safety and efficacy CPT- 11/ CF/5-Fu(IFL) versus FLF in previously untreated advanced or metastatic adoenocarcinoma of the stomach or gastroesophaged junction显示文摘 | Moehler MH Siebler J Hoehler T | 2003 | Proc Amsoc Clin Oncol2003，22，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员